ETHICAL POLICY

Psychiatry and Clinical Psychopharmacology is committed to the highest standards of research and publication ethics, and does not allow any form of plagiarism. All submitted manuscripts are screened with plagiarism software at least two times during the evaluation process to detect instances of overlapping and similar text. High even more than of a manuscript even after acceptance. The editors act.

Psychiatry and Clinical Psychopharmacology is committed to the maximum standards of publication ethics, and will not allow any kind of plagiarism. All submitted manuscripts are screened with a software to detect instances and similarity scores over 10% may lead rejection. Tt he editors act in accordance with international rules of publication and research ethics (COPE guidelines, ICMJE Recommendations, CSE White Paper on Publication Ethics, WAME resources, WMA policies and ORI). If the submitted manuscript requires ethics committee approval, it should be clearly stated within the text with name, date and number of approval and authors are asked to follow “WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects”, “Guide for the care and use of laboratory animals” ARRIVE guidelines – Animal Research: Reporting of In Vivo ExperimentsMedical Research Council and/or “International Guiding Principles for Biomedical Research Involving Animals” for all research studies. For manuscripts concerning clinical research including case reports, a statement should be included which shows informed consent of patients and volunteers. Authors should also clearly state any conflict of interest and financial support.